Brian Lanman

Brian Lanman

Company: Amgen

Job title: Director of Research


Advancing Covalent Hit-Finding: Lessons from Diverse Covalent Screening Campaigns 1:15 pm

Which screening strategies have proven effective in the identification of novel covalent inhibitors Factors to consider in the design of covalent screening libraries Hit triage and the role of structural biology in accelerating hit-to-lead effortsRead more

day: Conference Day Two

Panel Discussion: Identifying the Most Promising Hits to Advance Lead Optimization 2:15 pm

How to analyze screening data to recognize the covalent hits with the most drug-like properties Which factors affect hit quality beyond reactivity, target occupancy and speed of inactivation? How to deploy resources to optimize your most promising leads and develop effective compoundsRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.